Global Prostate Specific Antigen (PSA) Biomarker Market Growth (Status and Outlook) 2022-2028
- LP 4920356
- 101 Pages
- March 2022
- Medical Devices
The United States Prostate Specific Antigen (PSA) Biomarker market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prostate Specific Antigen (PSA) Biomarker market, reaching US$ million by the year 2028. As for the Europe Prostate Specific Antigen (PSA) Biomarker landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Prostate Specific Antigen (PSA) Biomarker players cover Abbott, Siemens Healthcare, DiaSorin, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen (PSA) Biomarker market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Blood
Semen
Urine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Diagnostics
Drug Discovery
Personalized Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size 2017-2028
2.1.2 Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Prostate Specific Antigen (PSA) Biomarker Segment by Type
2.2.1 Blood
2.2.2 Semen
2.2.3 Urine
2.3 Prostate Specific Antigen (PSA) Biomarker Market Size by Type
2.3.1 Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
2.4 Prostate Specific Antigen (PSA) Biomarker Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Prostate Specific Antigen (PSA) Biomarker Market Size by Application
2.5.1 Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
3 Prostate Specific Antigen (PSA) Biomarker Market Size by Player
3.1 Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Players
3.1.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2020-2022)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2020-2022)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Specific Antigen (PSA) Biomarker by Regions
4.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (2017-2022)
4.2 Americas Prostate Specific Antigen (PSA) Biomarker Market Size Growth (2017-2022)
4.3 APAC Prostate Specific Antigen (PSA) Biomarker Market Size Growth (2017-2022)
4.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size Growth (2017-2022)
4.5 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Growth (2017-2022)
5 Americas
5.1 Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022)
5.2 Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
5.3 Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022)
6.2 APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
6.3 APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker by Country (2017-2022)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker by Region (2017-2022)
8.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
8.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.1 Global Prostate Specific Antigen (PSA) Biomarker Forecast by Regions (2023-2028)
10.1.1 Global Prostate Specific Antigen (PSA) Biomarker Forecast by Regions (2023-2028)
10.1.2 Americas Prostate Specific Antigen (PSA) Biomarker Forecast
10.1.3 APAC Prostate Specific Antigen (PSA) Biomarker Forecast
10.1.4 Europe Prostate Specific Antigen (PSA) Biomarker Forecast
10.1.5 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Forecast
10.2 Americas Prostate Specific Antigen (PSA) Biomarker Forecast by Country (2023-2028)
10.2.1 United States Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.2.2 Canada Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.2.3 Mexico Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.2.4 Brazil Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3 APAC Prostate Specific Antigen (PSA) Biomarker Forecast by Region (2023-2028)
10.3.1 China Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3.2 Japan Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3.3 Korea Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3.4 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3.5 India Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.3.6 Australia Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.4 Europe Prostate Specific Antigen (PSA) Biomarker Forecast by Country (2023-2028)
10.4.1 Germany Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.4.2 France Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.4.3 UK Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.4.4 Italy Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.4.5 Russia Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.5 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Forecast by Region (2023-2028)
10.5.1 Egypt Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.5.2 South Africa Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.5.3 Israel Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.5.4 Turkey Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.5.5 GCC Countries Prostate Specific Antigen (PSA) Biomarker Market Forecast
10.6 Global Prostate Specific Antigen (PSA) Biomarker Forecast by Type (2023-2028)
10.7 Global Prostate Specific Antigen (PSA) Biomarker Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Prostate Specific Antigen (PSA) Biomarker Product Offered
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Information
11.2.2 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offered
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Siemens Healthcare Main Business Overview
11.2.5 Siemens Healthcare Latest Developments
11.3 DiaSorin
11.3.1 DiaSorin Company Information
11.3.2 DiaSorin Prostate Specific Antigen (PSA) Biomarker Product Offered
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 DiaSorin Main Business Overview
11.3.5 DiaSorin Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Prostate Specific Antigen (PSA) Biomarker Product Offered
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Information
11.5.2 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product Offered
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Tosoh Bioscience Main Business Overview
11.5.5 Tosoh Bioscience Latest Developments
11.6 Fujirebio
11.6.1 Fujirebio Company Information
11.6.2 Fujirebio Prostate Specific Antigen (PSA) Biomarker Product Offered
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fujirebio Main Business Overview
11.6.5 Fujirebio Latest Developments
11.7 BodiTech
11.7.1 BodiTech Company Information
11.7.2 BodiTech Prostate Specific Antigen (PSA) Biomarker Product Offered
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 BodiTech Main Business Overview
11.7.5 BodiTech Latest Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Information
11.8.2 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offered
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GE Healthcare Main Business Overview
11.8.5 GE Healthcare Latest Developments
11.9 Endocare
11.9.1 Endocare Company Information
11.9.2 Endocare Prostate Specific Antigen (PSA) Biomarker Product Offered
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Endocare Main Business Overview
11.9.5 Endocare Latest Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Information
11.10.2 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product Offered
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Quest Diagnostics Main Business Overview
11.10.5 Quest Diagnostics Latest Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Information
11.11.2 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product Offered
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio-Rad Laboratories Main Business Overview
11.11.5 Bio-Rad Laboratories Latest Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Information
11.12.2 QIAGEN Prostate Specific Antigen (PSA) Biomarker Product Offered
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 QIAGEN Main Business Overview
11.12.5 QIAGEN Latest Developments
11.13 Myriad RBM
11.13.1 Myriad RBM Company Information
11.13.2 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product Offered
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Myriad RBM Main Business Overview
11.13.5 Myriad RBM Latest Developments
12 Research Findings and Conclusion
Table 1. Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Blood
Table 3. Major Players of Semen
Table 4. Major Players of Urine
Table 5. Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
Table 8. Prostate Specific Antigen (PSA) Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
Table 11. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Player (2020-2022)
Table 13. Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Products Offered
Table 14. Prostate Specific Antigen (PSA) Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Regions (2017-2022)
Table 19. Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Country (2017-2022)
Table 21. Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
Table 23. Americas Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
Table 25. APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Region (2017-2022)
Table 27. APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
Table 29. APAC Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
Table 31. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Country (2017-2022)
Table 33. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
Table 35. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen (PSA) Biomarker
Table 44. Key Market Challenges & Risks of Prostate Specific Antigen (PSA) Biomarker
Table 45. Key Industry Trends of Prostate Specific Antigen (PSA) Biomarker
Table 46. Global Prostate Specific Antigen (PSA) Biomarker Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Prostate Specific Antigen (PSA) Biomarker Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Prostate Specific Antigen (PSA) Biomarker Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 53. Abbott Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 54. Abbott Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. Siemens Healthcare Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 58. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 59. Siemens Healthcare Main Business
Table 60. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Siemens Healthcare Latest Developments
Table 62. DiaSorin Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 63. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 64. DiaSorin Main Business
Table 65. DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. DiaSorin Latest Developments
Table 67. Roche Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 68. Roche Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 69. Roche Main Business
Table 70. Roche Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Roche Latest Developments
Table 72. Tosoh Bioscience Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 73. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 74. Tosoh Bioscience Main Business
Table 75. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Tosoh Bioscience Latest Developments
Table 77. Fujirebio Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 78. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 79. Fujirebio Main Business
Table 80. Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Fujirebio Latest Developments
Table 82. BodiTech Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 83. BodiTech Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 84. BodiTech Main Business
Table 85. BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. BodiTech Latest Developments
Table 87. GE Healthcare Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 88. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 89. GE Healthcare Main Business
Table 90. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. GE Healthcare Latest Developments
Table 92. Endocare Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 93. Endocare Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 94. Endocare Main Business
Table 95. Endocare Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Endocare Latest Developments
Table 97. Quest Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 98. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 99. Quest Diagnostics Main Business
Table 100. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Quest Diagnostics Latest Developments
Table 102. Bio-Rad Laboratories Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 103. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 104. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Bio-Rad Laboratories Main Business
Table 106. Bio-Rad Laboratories Latest Developments
Table 107. QIAGEN Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 108. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 109. QIAGEN Main Business
Table 110. QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. QIAGEN Latest Developments
Table 112. Myriad RBM Details, Company Type, Prostate Specific Antigen (PSA) Biomarker Area Served and Its Competitors
Table 113. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product Offered
Table 114. Myriad RBM Main Business
Table 115. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Myriad RBM Latest Developments
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type in 2021
Figure 7. Prostate Specific Antigen (PSA) Biomarker in Diagnostics
Figure 8. Global Prostate Specific Antigen (PSA) Biomarker Market: Diagnostics (2017-2022) & ($ Millions)
Figure 9. Prostate Specific Antigen (PSA) Biomarker in Drug Discovery
Figure 10. Global Prostate Specific Antigen (PSA) Biomarker Market: Drug Discovery (2017-2022) & ($ Millions)
Figure 11. Prostate Specific Antigen (PSA) Biomarker in Personalized Medicine
Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Market: Personalized Medicine (2017-2022) & ($ Millions)
Figure 13. Prostate Specific Antigen (PSA) Biomarker in Others
Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application in 2021
Figure 16. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Player in 2021
Figure 17. Global Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Prostate Specific Antigen (PSA) Biomarker Market Size 2017-2022 ($ Millions)
Figure 19. APAC Prostate Specific Antigen (PSA) Biomarker Market Size 2017-2022 ($ Millions)
Figure 20. Europe Prostate Specific Antigen (PSA) Biomarker Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size 2017-2022 ($ Millions)
Figure 22. Americas Prostate Specific Antigen (PSA) Biomarker Value Market Share by Country in 2021
Figure 23. Americas Prostate Specific Antigen (PSA) Biomarker Consumption Market Share by Type in 2021
Figure 24. Americas Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application in 2021
Figure 25. United States Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Region in 2021
Figure 30. APAC Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application in 2021
Figure 31. China Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Country in 2021
Figure 38. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type in 2021
Figure 39. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application in 2021
Figure 40. Germany Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application in 2021
Figure 48. Egypt Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Prostate Specific Antigen (PSA) Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 54. APAC Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 55. Europe Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 57. United States Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 58. Canada Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 61. China Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 62. Japan Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 63. Korea Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 65. India Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 66. Australia Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 67. Germany Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 68. France Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 69. UK Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 70. Italy Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 71. Russia Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 72. Spain Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 75. Israel Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Prostate Specific Antigen (PSA) Biomarker Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
